HEADER    PEPTIDE BINDING PROTEIN                 09-NOV-20   7AXM              
TITLE     STRUCTURE OF SARS-COV-2 MAIN PROTEASE BOUND TO PELITINIB              
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: 3C-LIKE PROTEINASE;                                        
COMPND   3 CHAIN: A;                                                            
COMPND   4 SYNONYM: 3CL-PRO,3CLP,MAIN PROTEASE,MPRO,NON-STRUCTURAL PROTEIN 5,   
COMPND   5 NSP5,SARS CORONAVIRUS MAIN PROTEINASE;                               
COMPND   6 EC: 3.4.22.69;                                                       
COMPND   7 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS   
SOURCE   3 2;                                                                   
SOURCE   4 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2;                              
SOURCE   5 ORGANISM_TAXID: 2697049;                                             
SOURCE   6 GENE: REP, 1A-1B;                                                    
SOURCE   7 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   8 EXPRESSION_SYSTEM_TAXID: 562                                         
KEYWDS    INHIBITOR, COMPLEX, SCREEN, SARS-COV-2, PEPTIDE BINDING PROTEIN       
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    S.GUENTHER,P.Y.A.REINKE,D.OBERTHUER,O.YEFANOV,L.GELISIO,H.GINN,       
AUTHOR   2 J.LIESKE,M.DOMARACKY,W.BREHM,A.RAHMANI MASHOUR,T.A.WHITE,J.KNOSKA,   
AUTHOR   3 G.PENA ESPERANZA,F.KOUA,A.TOLSTIKOVA,M.GROESSLER,P.FISCHER,          
AUTHOR   4 V.HENNICKE,H.FLECKENSTEIN,F.TROST,M.GALCHENKOVA,Y.GEVORKOV,C.LI,     
AUTHOR   5 S.AWEL,L.X.PAULRAJ,N.ULLAH,S.FALKE,B.ALVES FRANCA,M.SCHWINZER,       
AUTHOR   6 H.BROGNARO,N.WERNER,M.PERBANDT,H.TIDOW,B.SEYCHELL,T.BECK,S.MEIER,    
AUTHOR   7 J.J.DOYLE,H.GISELER,D.MELO,T.J.LANE,I.DUNKEL,A.PECK,S.SAOUANE,       
AUTHOR   8 J.HAKANPAEAE,J.MEYER,H.NOEI,P.GRIBBON,B.ELLINGER,M.KUZIKOV,M.WOLF,   
AUTHOR   9 L.ZHANG,C.EHRT,J.PLETZER-ZELGERT,J.WOLLENHAUPT,C.FEILER,M.WEISS,     
AUTHOR  10 E.C.SCHULZ,P.MEHRABI,B.NORTON-BAKER,C.SCHMIDT,K.LORENZEN,R.SCHUBERT, 
AUTHOR  11 H.HAN,A.CHARI,Y.FERNANDEZ GARCIA,D.TURK,R.HILGENFELD,M.RAREY,        
AUTHOR  12 A.ZALIANI,H.N.CHAPMAN,A.PEARSON,C.BETZEL,A.MEENTS                    
REVDAT   4   19-MAY-21 7AXM    1       JRNL                                     
REVDAT   3   14-APR-21 7AXM    1       COMPND SOURCE JRNL                       
REVDAT   2   09-DEC-20 7AXM    1       JRNL   REMARK                            
REVDAT   1   02-DEC-20 7AXM    0                                                
JRNL        AUTH   S.GUNTHER,P.Y.A.REINKE,Y.FERNANDEZ-GARCIA,J.LIESKE,T.J.LANE, 
JRNL        AUTH 2 H.M.GINN,F.H.M.KOUA,C.EHRT,W.EWERT,D.OBERTHUER,O.YEFANOV,    
JRNL        AUTH 3 S.MEIER,K.LORENZEN,B.KRICHEL,J.D.KOPICKI,L.GELISIO,W.BREHM,  
JRNL        AUTH 4 I.DUNKEL,B.SEYCHELL,H.GIESELER,B.NORTON-BAKER,               
JRNL        AUTH 5 B.ESCUDERO-PEREZ,M.DOMARACKY,S.SAOUANE,A.TOLSTIKOVA,         
JRNL        AUTH 6 T.A.WHITE,A.HANLE,M.GROESSLER,H.FLECKENSTEIN,F.TROST,        
JRNL        AUTH 7 M.GALCHENKOVA,Y.GEVORKOV,C.LI,S.AWEL,A.PECK,M.BARTHELMESS,   
JRNL        AUTH 8 F.SCHLUNZEN,P.LOURDU XAVIER,N.WERNER,H.ANDALEEB,N.ULLAH,     
JRNL        AUTH 9 S.FALKE,V.SRINIVASAN,B.A.FRANCA,M.SCHWINZER,H.BROGNARO,      
JRNL        AUTH10 C.ROGERS,D.MELO,J.J.ZAITSEVA-DOYLE,J.KNOSKA,                 
JRNL        AUTH11 G.E.PENA-MURILLO,A.R.MASHHOUR,V.HENNICKE,P.FISCHER,          
JRNL        AUTH12 J.HAKANPAA,J.MEYER,P.GRIBBON,B.ELLINGER,M.KUZIKOV,M.WOLF,    
JRNL        AUTH13 A.R.BECCARI,G.BOURENKOV,D.VON STETTEN,G.POMPIDOR,I.BENTO,    
JRNL        AUTH14 S.PANNEERSELVAM,I.KARPICS,T.R.SCHNEIDER,M.M.GARCIA-ALAI,     
JRNL        AUTH15 S.NIEBLING,C.GUNTHER,C.SCHMIDT,R.SCHUBERT,H.HAN,J.BOGER,     
JRNL        AUTH16 D.C.F.MONTEIRO,L.ZHANG,X.SUN,J.PLETZER-ZELGERT,              
JRNL        AUTH17 J.WOLLENHAUPT,C.G.FEILER,M.S.WEISS,E.C.SCHULZ,P.MEHRABI,     
JRNL        AUTH18 K.KARNICAR,A.USENIK,J.LOBODA,H.TIDOW,A.CHARI,R.HILGENFELD,   
JRNL        AUTH19 C.UETRECHT,R.COX,A.ZALIANI,T.BECK,M.RAREY,S.GUNTHER,D.TURK,  
JRNL        AUTH20 W.HINRICHS,H.N.CHAPMAN,A.R.PEARSON,C.BETZEL,A.MEENTS         
JRNL        TITL   X-RAY SCREENING IDENTIFIES ACTIVE SITE AND ALLOSTERIC        
JRNL        TITL 2 INHIBITORS OF SARS-COV-2 MAIN PROTEASE.                      
JRNL        REF    SCIENCE                       V. 372   642 2021              
JRNL        REFN                   ESSN 1095-9203                               
JRNL        PMID   33811162                                                     
JRNL        DOI    10.1126/SCIENCE.ABF7945                                      
REMARK   1                                                                      
REMARK   1 REFERENCE 1                                                          
REMARK   1  AUTH   S.GUENTHER,P.Y.A.,REINKE,Y.,FERNANDEZ-GARCIA,J.,LIESKE,T.J., 
REMARK   1  AUTH 2 LANE,H.M.,GINN,F.H.M.,KOUA,C.,EHRT,W.,EWERT,D.,OBERTHUER,O., 
REMARK   1  AUTH 3 YEFANOV,S.,MEIER,K.,LORENZEN,B.,KRICHEL,J.D.,KOPICKI,L.,     
REMARK   1  AUTH 4 GELISIO,W.,BREHM,I.,DUNKEL,B.,SEYCHELL,H.,GIESELER,B.,       
REMARK   1  AUTH 5 NORTON-BAKER,B.,ESCUDERO-PEREZ,M.,DOMARACKY,S.,SAOUANE,A.,   
REMARK   1  AUTH 6 TOLSTIKOVA,T.A.,WHITE,A.,HANLE,M.,GROESSLER,H.,FLECKENSTEIN, 
REMARK   1  AUTH 7 F.,TROST,M.,GALCHENKOVA,Y.,GEVORKOV,C.,LI,S.,AWEL,A.PECK,M., 
REMARK   1  AUTH 8 BARTHELMESS,F.,SCHLUENZEN,L.X.,PAULRAJ,N.,WERNER,H.,         
REMARK   1  AUTH 9 ANDALEEB,N.,ULLAH,S.,FALKE,V.,SRINIVASAN,B.,FRANCA,M.,       
REMARK   1  AUTH10 SCHWINZER,H.,BROGNARO,C.,ROGERS,D.,MELO,J.J.,DOYLE,J.,       
REMARK   1  AUTH11 KNOSKA,G.E.,PENA MURILLO,A.,RAHMANI MASHHOUR,F.,GUICKING,V., 
REMARK   1  AUTH12 HENNICKE,P.,FISCHER,J.,HAKANPAEAE,J.,MEYER,P.,GRIBBON,B.,    
REMARK   1  AUTH13 ELLINGER,M.,KUZIKOV,M.,WOLF,G.,BURENKOV,D.,VON STETTEN,G.,   
REMARK   1  AUTH14 POMPIDOR,I.,BENTO,S.,PANNEERSELVAM,I.,KARPICS,T.R.,          
REMARK   1  AUTH15 SCHNEIDER,M.,GARCIA ALAI,S.,NIEBLING,C.,GUENTHER,C.,SCHMIDT, 
REMARK   1  AUTH16 R.,SCHUBERT,H.,HAN,J.,BOGER,D.,MONTEIRO,L.,ZHANG,X.,SUN,J.,  
REMARK   1  AUTH17 PLETZER-ZELGERT,J.,WOLLENHAUPT,C.,FEILER,M.,WEISS,E.C.,      
REMARK   1  AUTH18 SCHULZ,P.,MEHRABI,K.,KARNICAR,A.,USENIK,J.,LOBODA,H.,TIDOW,  
REMARK   1  AUTH19 A.,CHARI,R.,HILGENFELD,C.,UETRECHT,R.,COX,A.,ZALIANI,T.,     
REMARK   1  AUTH20 BECK,M.,RAREY,S.,GUENTHER,D.,TURK,W.,HINRICHS,H.N.,CHAPMAN,  
REMARK   1  AUTH21 A.,PEARSON,C.,BETZEL,A.MEENTS                                
REMARK   1  TITL   INHIBITION OF SARS-COV-2 MAIN PROTEASE BY ALLOSTERIC         
REMARK   1  TITL 2 DRUG-BINDING                                                 
REMARK   1  REF    BIORXIV                                    2020              
REMARK   1  REFN                                                                
REMARK   1  DOI    10.1101/2020.11.12.378422                                    
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.40 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : PHENIX 1.17.1_3660                                   
REMARK   3   AUTHORS     : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN            
REMARK   3               : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE,           
REMARK   3               : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER,            
REMARK   3               : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY,              
REMARK   3               : REETAL PAI,RANDY READ,JANE RICHARDSON,               
REMARK   3               : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI,           
REMARK   3               : NICHOLAS SAUTER,JACOB SMITH,LAURENT                  
REMARK   3               : STORONI,TOM TERWILLIGER,PETER ZWART                  
REMARK   3                                                                      
REMARK   3    REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2           
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 26.60                          
REMARK   3   MIN(FOBS/SIGMA_FOBS)              : 1.340                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : 98.6                           
REMARK   3   NUMBER OF REFLECTIONS             : 50427                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   R VALUE     (WORKING + TEST SET) : 0.145                           
REMARK   3   R VALUE            (WORKING SET) : 0.143                           
REMARK   3   FREE R VALUE                     : 0.210                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 3.970                           
REMARK   3   FREE R VALUE TEST SET COUNT      : 2000                            
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT (IN BINS).                           
REMARK   3   BIN  RESOLUTION RANGE  COMPL.    NWORK NFREE   RWORK  RFREE        
REMARK   3     1 26.6000 -  3.3700    1.00     3590   149  0.1292 0.1923        
REMARK   3     2  3.3700 -  2.6800    1.00     3528   146  0.1319 0.1856        
REMARK   3     3  2.6800 -  2.3400    1.00     3519   145  0.1274 0.1987        
REMARK   3     4  2.3400 -  2.1300    1.00     3495   143  0.1188 0.1797        
REMARK   3     5  2.1300 -  1.9700    1.00     3507   146  0.1250 0.2102        
REMARK   3     6  1.9700 -  1.8600    0.99     3465   142  0.1323 0.1954        
REMARK   3     7  1.8600 -  1.7600    0.99     3457   143  0.1478 0.2367        
REMARK   3     8  1.7600 -  1.6900    0.99     3447   143  0.1597 0.2419        
REMARK   3     9  1.6900 -  1.6200    0.98     3437   141  0.1845 0.2556        
REMARK   3    10  1.6200 -  1.5700    0.98     3434   142  0.2009 0.2899        
REMARK   3    11  1.5700 -  1.5200    0.98     3450   142  0.2193 0.3116        
REMARK   3    12  1.5200 -  1.4700    0.98     3395   141  0.2344 0.2631        
REMARK   3    13  1.4700 -  1.4400    0.98     3420   141  0.2759 0.3508        
REMARK   3    14  1.4400 -  1.4000    0.95     3283   136  0.3126 0.3607        
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELLING.                                             
REMARK   3   METHOD USED        : FLAT BULK SOLVENT MODEL                       
REMARK   3   SOLVENT RADIUS     : 1.11                                          
REMARK   3   SHRINKAGE RADIUS   : 0.90                                          
REMARK   3   K_SOL              : NULL                                          
REMARK   3   B_SOL              : NULL                                          
REMARK   3                                                                      
REMARK   3  ERROR ESTIMATES.                                                    
REMARK   3   COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED)     : 0.191            
REMARK   3   PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.804           
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : 18.59                          
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 27.29                          
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : NULL                                                 
REMARK   3    B22 (A**2) : NULL                                                 
REMARK   3    B33 (A**2) : NULL                                                 
REMARK   3    B12 (A**2) : NULL                                                 
REMARK   3    B13 (A**2) : NULL                                                 
REMARK   3    B23 (A**2) : NULL                                                 
REMARK   3                                                                      
REMARK   3  TWINNING INFORMATION.                                               
REMARK   3   FRACTION: NULL                                                     
REMARK   3   OPERATOR: NULL                                                     
REMARK   3                                                                      
REMARK   3  DEVIATIONS FROM IDEAL VALUES.                                       
REMARK   3                 RMSD          COUNT                                  
REMARK   3   BOND      :  0.010           2600                                  
REMARK   3   ANGLE     :  1.172           3545                                  
REMARK   3   CHIRALITY :  0.087            386                                  
REMARK   3   PLANARITY :  0.008            467                                  
REMARK   3   DIHEDRAL  : 18.594            960                                  
REMARK   3                                                                      
REMARK   3  TLS DETAILS                                                         
REMARK   3   NUMBER OF TLS GROUPS  : NULL                                       
REMARK   3                                                                      
REMARK   3  NCS DETAILS                                                         
REMARK   3   NUMBER OF NCS GROUPS : NULL                                        
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 7AXM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 11-NOV-20.                  
REMARK 100 THE DEPOSITION ID IS D_1292112251.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 28-APR-20                          
REMARK 200  TEMPERATURE           (KELVIN) : 100                                
REMARK 200  PH                             : 7.5                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : PETRA III, DESY                    
REMARK 200  BEAMLINE                       : P11                                
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.033                              
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : PIXEL                              
REMARK 200  DETECTOR MANUFACTURER          : DECTRIS PILATUS 6M-F               
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DIALS                              
REMARK 200  DATA SCALING SOFTWARE          : DIALS                              
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 50456                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.400                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 26.600                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL                               
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 98.6                               
REMARK 200  DATA REDUNDANCY                : 3.800                              
REMARK 200  R MERGE                    (I) : NULL                               
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 10.0700                            
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.45                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : NULL                               
REMARK 200  DATA REDUNDANCY IN SHELL       : NULL                               
REMARK 200  R MERGE FOR SHELL          (I) : NULL                               
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : NULL                               
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: PHENIX                                                
REMARK 200 STARTING MODEL: 6NYQ                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 36.31                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.93                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MIB PH 7.5, 25% PEG1500, 5%        
REMARK 280  DMSO, VAPOR DIFFUSION, TEMPERATURE 291K                             
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1                          
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X,Y,-Z                                                 
REMARK 290       3555   X+1/2,Y+1/2,Z                                           
REMARK 290       4555   -X+1/2,Y+1/2,-Z                                         
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000 -1.000000        0.00000            
REMARK 290   SMTRY1   3  1.000000  0.000000  0.000000       56.70000            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       26.60000            
REMARK 290   SMTRY3   3  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   4 -1.000000  0.000000  0.000000       56.70000            
REMARK 290   SMTRY2   4  0.000000  1.000000  0.000000       26.60000            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC                           
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC                    
REMARK 350 SOFTWARE USED: PISA                                                  
REMARK 350 TOTAL BURIED SURFACE AREA: 4800 ANGSTROM**2                          
REMARK 350 SURFACE AREA OF THE COMPLEX: 26260 ANGSTROM**2                       
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL                          
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350   BIOMT1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   2  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   2  0.000000  0.000000 -1.000000        0.00000            
REMARK 375                                                                      
REMARK 375 SPECIAL POSITION                                                     
REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS            
REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL          
REMARK 375 POSITIONS.                                                           
REMARK 375                                                                      
REMARK 375 ATOM RES CSSEQI                                                      
REMARK 375      HOH A 847  LIES ON A SPECIAL POSITION.                          
REMARK 375      HOH A 928  LIES ON A SPECIAL POSITION.                          
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ASP A  33     -130.18     53.27                                   
REMARK 500    ASN A  51       67.97   -155.36                                   
REMARK 500    ASN A  51       67.97   -155.31                                   
REMARK 500    ASN A  84     -120.60     53.62                                   
REMARK 500    TYR A 154      -96.52     35.54                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 525                                                                      
REMARK 525 SOLVENT                                                              
REMARK 525                                                                      
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT                    
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST                  
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT                 
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE                       
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;                             
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE                  
REMARK 525 NUMBER; I=INSERTION CODE):                                           
REMARK 525                                                                      
REMARK 525  M RES CSSEQI                                                        
REMARK 525    HOH A 957        DISTANCE =  6.00 ANGSTROMS                       
REMARK 525    HOH A 958        DISTANCE =  6.14 ANGSTROMS                       
REMARK 525    HOH A 959        DISTANCE =  6.34 ANGSTROMS                       
REMARK 525    HOH A 960        DISTANCE =  6.45 ANGSTROMS                       
REMARK 525    HOH A 961        DISTANCE =  6.57 ANGSTROMS                       
REMARK 525    HOH A 962        DISTANCE =  6.66 ANGSTROMS                       
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 501                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue 93J A 502                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC3                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 503                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC4                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 504                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC5                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 505                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC6                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue IMD A 506                 
DBREF  7AXM A    1   306  UNP    P0DTD1   R1AB_SARS2    3264   3569             
SEQRES   1 A  306  SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL          
SEQRES   2 A  306  GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR          
SEQRES   3 A  306  LEU ASN GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO          
SEQRES   4 A  306  ARG HIS VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO          
SEQRES   5 A  306  ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN          
SEQRES   6 A  306  PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE          
SEQRES   7 A  306  GLY HIS SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL          
SEQRES   8 A  306  ASP THR ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL          
SEQRES   9 A  306  ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS          
SEQRES  10 A  306  TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET          
SEQRES  11 A  306  ARG PRO ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY          
SEQRES  12 A  306  SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS          
SEQRES  13 A  306  VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR          
SEQRES  14 A  306  GLY VAL HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR          
SEQRES  15 A  306  GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY          
SEQRES  16 A  306  THR ASP THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU          
SEQRES  17 A  306  TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN          
SEQRES  18 A  306  ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA          
SEQRES  19 A  306  MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL          
SEQRES  20 A  306  ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA          
SEQRES  21 A  306  VAL LEU ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN          
SEQRES  22 A  306  ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU          
SEQRES  23 A  306  LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN          
SEQRES  24 A  306  CYS SER GLY VAL THR PHE GLN                                  
HET    DMS  A 501      10                                                       
HET    93J  A 502      56                                                       
HET    DMS  A 503      10                                                       
HET    DMS  A 504      10                                                       
HET    DMS  A 505      10                                                       
HET    IMD  A 506      10                                                       
HETNAM     DMS DIMETHYL SULFOXIDE                                               
HETNAM     93J (2E)-N-{4-[(3-CHLORO-4-FLUOROPHENYL)AMINO]-3-CYANO-7-            
HETNAM   2 93J  ETHOXYQUINOLIN-6-YL}-4-(DIMETHYLAMINO)BUT-2-ENAMIDE             
HETNAM     IMD IMIDAZOLE                                                        
FORMUL   2  DMS    4(C2 H6 O S)                                                 
FORMUL   3  93J    C24 H23 CL F N5 O2                                           
FORMUL   7  IMD    C3 H5 N2 1+                                                  
FORMUL   8  HOH   *362(H2 O)                                                    
SITE     1 AC1  6 PHE A 140  LEU A 141  ASN A 142  HIS A 163                    
SITE     2 AC1  6 MET A 165  GLU A 166                                          
SITE     1 AC2 12 THR A  26  TYR A 118  ASN A 119  ASN A 142                    
SITE     2 AC2 12 GLY A 143  ILE A 213  LEU A 253  GLN A 256                    
SITE     3 AC2 12 CYS A 300  SER A 301  HOH A 667  HOH A 880                    
SITE     1 AC3  8 GLN A  74  LEU A  75  ARG A  76  PHE A 223                    
SITE     2 AC3  8 THR A 224  ASP A 263  HOH A 684  HOH A 687                    
SITE     1 AC4  4 GLY A  15  MET A  17  LYS A  97  HOH A 739                    
SITE     1 AC5  5 MET A   6  PHE A   8  SER A 123  GLN A 127                    
SITE     2 AC5  5 ARG A 298                                                     
SITE     1 AC6  2 TYR A 101  PHE A 103                                          
CRYST1  113.400   53.200   44.776  90.00 103.05  90.00 C 1 2 1       4          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.008818  0.000000  0.002045        0.00000                         
SCALE2      0.000000  0.018797  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.022926        0.00000                         
HETATM    1  C10 93J A 502       5.438   0.333 -20.159  0.61 47.24           C
ANISOU    1  C10 93J A 502     7911   5785   4255  -1450   2427    994       C
HETATM    2  C13 93J A 502       4.178  -2.163 -20.211  0.61 49.45           C
ANISOU    2  C13 93J A 502     7889   5753   5146  -1307   2536   1326       C
HETATM    3  C15 93J A 502       4.034   0.257 -20.217  0.61 47.76           C
ANISOU    3  C15 93J A 502     7968   5851   4329  -1314   2526    790       C
HETATM    4  C17 93J A 502       1.966  -3.254 -18.575  0.61 49.27           C
ANISOU    4  C17 93J A 502     7746   4972   6004  -1360   2612   1450       C
HETATM    5  C20 93J A 502       7.964   3.314 -18.413  0.61 48.11           C
ANISOU    5  C20 93J A 502     7757   6901   3620  -1786   2100      2       C
HETATM    6  C21 93J A 502       8.927   4.194 -17.955  0.61 47.82           C
ANISOU    6  C21 93J A 502     7754   7138   3276  -1761   1824   -327       C
HETATM    7  C22 93J A 502      10.130   4.321 -18.628  0.61 50.60           C
ANISOU    7  C22 93J A 502     7846   7309   4070  -1781   1751   -462       C
HETATM    8  C24 93J A 502       9.466   2.689 -20.197  0.61 48.10           C
ANISOU    8  C24 93J A 502     7840   7069   3366  -1784   2073   -132       C
HETATM    9  C01 93J A 502       7.754  -3.368 -20.338  0.61 49.56           C
ANISOU    9  C01 93J A 502     7899   6589   4343   -629   1902    132       C
HETATM   10  C02 93J A 502       8.328  -4.754 -20.478  0.61 50.77           C
ANISOU   10  C02 93J A 502     7858   6980   4452   -416   1786    241       C
HETATM   11  C03 93J A 502       9.576  -5.128 -20.889  0.61 52.67           C
ANISOU   11  C03 93J A 502     7813   7351   4848   -200   1563    568       C
HETATM   12  C04 93J A 502      10.290  -6.476 -20.660  0.61 52.97           C
ANISOU   12  C04 93J A 502     7757   7598   4770    -93   1390    900       C
HETATM   13  O01 93J A 502       8.466  -2.365 -20.366  0.61 48.77           O
ANISOU   13  O01 93J A 502     7961   6584   3986   -633   1892   -343       O
HETATM   14  N01 93J A 502       6.403  -3.272 -20.173  0.61 48.36           N
ANISOU   14  N01 93J A 502     7866   6173   4336   -855   2149    510       N
HETATM   15  N02 93J A 502      11.501  -6.851 -21.480  0.61 53.12           N
ANISOU   15  N02 93J A 502     7718   7764   4701    -37   1263   1325       N
HETATM   16  C05 93J A 502      11.373  -8.152 -22.119  0.61 52.13           C
ANISOU   16  C05 93J A 502     7681   7499   4629    -31   1240   1525       C
HETATM   17  C06 93J A 502      12.739  -6.849 -20.711  0.61 52.33           C
ANISOU   17  C06 93J A 502     7707   7824   4351     80   1220   1542       C
HETATM   18  N03 93J A 502       3.212   1.333 -20.260  0.61 48.73           N
ANISOU   18  N03 93J A 502     8004   5902   4610  -1347   2592    685       N
HETATM   19  C07 93J A 502       3.766   2.505 -20.223  0.61 48.89           C
ANISOU   19  C07 93J A 502     7976   5815   4786  -1484   2659    840       C
HETATM   20  C08 93J A 502       5.188   2.705 -20.213  0.61 50.13           C
ANISOU   20  C08 93J A 502     7972   5781   5294  -1478   2506    703       C
HETATM   21  C09 93J A 502       6.041   1.602 -20.121  0.61 48.49           C
ANISOU   21  C09 93J A 502     7938   5908   4577  -1429   2316    634       C
HETATM   22  C11 93J A 502       6.193  -0.878 -20.145  0.61 46.71           C
ANISOU   22  C11 93J A 502     7766   5818   4162  -1310   2361   1116       C
HETATM   23  C12 93J A 502       5.584  -2.103 -20.151  0.61 48.61           C
ANISOU   23  C12 93J A 502     7887   5957   4626  -1169   2274    973       C
HETATM   24  C14 93J A 502       3.429  -1.012 -20.243  0.61 47.82           C
ANISOU   24  C14 93J A 502     7881   5811   4478  -1323   2574   1096       C
HETATM   25  O02 93J A 502       3.555  -3.384 -20.270  0.61 51.73           O
ANISOU   25  O02 93J A 502     7874   5670   6111  -1269   2505   1067       O
HETATM   26  C16 93J A 502       2.142  -3.422 -20.024  0.61 51.32           C
ANISOU   26  C16 93J A 502     7807   5402   6289  -1314   2497   1230       C
HETATM   27  C18 93J A 502       5.477   4.110 -20.231  0.61 50.01           C
ANISOU   27  C18 93J A 502     7872   5409   5719  -1581   2768   1331       C
HETATM   28  N04 93J A 502       5.635   5.235 -20.297  0.61 50.48           N
ANISOU   28  N04 93J A 502     7892   5265   6023  -1618   2853   1274       N
HETATM   29  N05 93J A 502       7.372   1.674 -20.106  0.61 46.05           N
ANISOU   29  N05 93J A 502     7798   6115   3583  -1555   2188    544       N
HETATM   30  C19 93J A 502       8.233   2.578 -19.566  0.61 46.13           C
ANISOU   30  C19 93J A 502     7644   6531   3350  -1628   2076    298       C
HETATM   31  C23 93J A 502      10.424   3.565 -19.721  0.61 48.66           C
ANISOU   31  C23 93J A 502     7834   7258   3395  -1807   2043   -334       C
HETATM   32  F01 93J A 502      11.087   5.132 -18.175  0.61 52.48           F
ANISOU   32  F01 93J A 502     7951   7309   4680  -1676   1689   -464       F
HETATM   33 CL1  93J A 502       8.541   5.130 -16.564  0.61 49.42          Cl
ANISOU   33 CL1  93J A 502     7682   7237   3858  -1891   1492   -238      Cl
HETATM   34  H20 93J A 502       7.026   3.200 -17.890  0.61  0.00           H
HETATM   35  H24 93J A 502       9.678   2.086 -21.067  0.61  0.00           H
HETATM   36  H02 93J A 502       7.661  -5.563 -20.218  0.61  0.00           H
HETATM   37  H03 93J A 502      10.132  -4.387 -21.444  0.61  0.00           H
HETATM   38 H042 93J A 502      10.603  -6.490 -19.616  0.61  0.00           H
HETATM   39 H043 93J A 502       9.549  -7.265 -20.790  0.61  0.00           H
HETATM   40  H01 93J A 502       5.916  -4.148 -20.050  0.61  0.00           H
HETATM   41 HN02 93J A 502      11.597  -6.162 -22.212  0.61  0.00           H
HETATM   42  H07 93J A 502       3.126   3.374 -20.198  0.61  0.00           H
HETATM   43  H11 93J A 502       7.272  -0.826 -20.129  0.61  0.00           H
HETATM   44  H14 93J A 502       2.352  -1.083 -20.289  0.61  0.00           H
HETATM   45 H162 93J A 502       1.645  -2.613 -20.560  0.61  0.00           H
HETATM   46 H163 93J A 502       1.735  -4.383 -20.339  0.61  0.00           H
HETATM   47 HN05 93J A 502       7.828   0.912 -20.587  0.61  0.00           H
HETATM   48  H23 93J A 502      11.385   3.648 -20.206  0.61  0.00           H
HETATM   49 H171 93J A 502       0.904  -3.276 -18.333  0.61  0.00           H
HETATM   50 H172 93J A 502       2.390  -2.298 -18.266  0.61  0.00           H
HETATM   51 H173 93J A 502       2.475  -4.063 -18.051  0.61  0.00           H
HETATM   52 H051 93J A 502      10.453  -8.182 -22.703  0.61  0.00           H
HETATM   53 H052 93J A 502      12.226  -8.319 -22.777  0.61  0.00           H
HETATM   54 H053 93J A 502      11.345  -8.930 -21.356  0.61  0.00           H
HETATM   55 H061 93J A 502      12.861  -5.883 -20.220  0.61  0.00           H
HETATM   56 H062 93J A 502      13.582  -7.025 -21.379  0.61  0.00           H
HETATM   57 H063 93J A 502      12.701  -7.637 -19.959  0.61  0.00           H
CONECT    9   10   13   14
CONECT   10    9   11   36
CONECT   11   10   12   37
CONECT   12   11   15   38   39
CONECT   16   15   54   52   53
CONECT   17   15   55   56   57
CONECT   19   18   20   42
CONECT   20   19   21   27
CONECT   21    1   20   29
CONECT    1    3   21   22
CONECT   22    1   23   43
CONECT   23    2   14   22
CONECT    2   23   24   25
CONECT   24    2    3   44
CONECT    3    1   18   24
CONECT   26    4   25   45   46
CONECT    4   26   49   50   51
CONECT   27   20   28
CONECT   30    5    8   29
CONECT    5    6   30   34
CONECT    6    5    7   33
CONECT    7    6   31   32
CONECT   31    7    8   48
CONECT    8   30   31   35
CONECT   33    6
CONECT   32    7
CONECT   40   14
CONECT   36   10
CONECT   37   11
CONECT   38   12
CONECT   39   12
CONECT   52   16
CONECT   53   16
CONECT   54   16
CONECT   55   17
CONECT   56   17
CONECT   57   17
CONECT   42   19
CONECT   43   22
CONECT   44   24
CONECT   45   26
CONECT   46   26
CONECT   49    4
CONECT   50    4
CONECT   51    4
CONECT   34    5
CONECT   48   31
CONECT   35    8
CONECT   41   15
CONECT   47   29
CONECT   14    9   23   40
CONECT   15   12   16   17   41
CONECT   18    3   19
CONECT   28   27
CONECT   29   21   30   47
CONECT   13    9
CONECT   25    2   26
END
